Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Angle Plc ADR (ANPCY)

Angle Plc ADR (ANPCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2000 +12.50%
on 11/22/24
1.4700 -8.16%
on 12/02/24
-0.1500 (-10.00%)
since 11/18/24
3-Month
0.7362 +83.37%
on 10/25/24
1.6800 -19.64%
on 09/19/24
+0.2100 (+18.42%)
since 09/13/24
52-Week
0.7362 +83.37%
on 10/25/24
4.0000 -66.25%
on 01/04/24
-0.2800 (-17.18%)
since 12/15/23

Most Recent Stories

More News
Angle PLC Announces HER2 Presentation at SABCS

WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM

ANPCY : 1.3500 (-8.16%)
AGL : 1.9700 (+4.79%)
ANGLE presents two posters at EACR

PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCE

ANPCY : 1.3500 (-8.16%)
AGL : 1.9700 (+4.79%)
Angle PLC Announces Publication Demonstrates CTC Profiling Potential

PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCER

ANPCY : 1.3500 (-8.16%)
AGL : 1.9700 (+4.79%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)
Angle PLC Announces Result of 2022 Annual General Meeting

GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep

BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP

ANPCY : 1.3500 (-8.16%)
AGL.LN : 9.333 (-4.28%)
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep

BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP

ANPCY : 1.3500 (-8.16%)
AGL.LN : 9.333 (-4.28%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)
Angle PLC Announces Secured Contract From Pharma Services Customer

Additional contract for a new clinical trial

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)
Angle PLC Announces Predicting Immunotherapy Response in SCLC

PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCER

AGL : 1.9700 (+4.79%)
ANPCY : 1.3500 (-8.16%)

Business Summary

ANGLE PLC was incorporated on December 04, 2003 in England and Wales. It is a commercially driven specialist medical diagnostic company with products in cancer diagnostics and foetal health. The Company is commercializing a platform technology that can capture cells circulating in blood, such as cancer...

See More

Key Turning Points

3rd Resistance Point 1.3500
2nd Resistance Point 1.3500
1st Resistance Point 1.3500
Last Price 1.3500
1st Support Level 1.3500
2nd Support Level 1.3500
3rd Support Level 1.3500

See More

52-Week High 4.0000
Fibonacci 61.8% 2.7532
Fibonacci 50% 2.3681
Fibonacci 38.2% 1.9830
Last Price 1.3500
52-Week Low 0.7362

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar